The epidemiology of human papillomavirus infections
- PMID: 15753008
- DOI: 10.1016/j.jcv.2004.12.008
The epidemiology of human papillomavirus infections
Abstract
Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical cancer, the second most frequently occurring cancer in women worldwide. Rates of acquisition of HPV are high, particularly among sexually active young adults. Reported estimates of incident HPV infection among initially negative women have reached as high as 60% over a 5-year follow-up period. In this article, we review the epidemiology of HPV infection. In addition to estimates of disease frequency, we highlight risk factors for HPV infection, including the number of lifetime sex partners, which is the most salient risk factor. We discuss significant issues surrounding the natural history of HPV infection, including viral persistence versus clearance, immune response, development of lesions and development of cancer. Finally, we discuss strategies for preventing HPV infection.
Similar articles
-
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.Sex Transm Dis. 2009 May;36(5):305-11. doi: 10.1097/OLQ.0b013e318194eb76. Sex Transm Dis. 2009. PMID: 19295468
-
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064. Vaccine. 2008. PMID: 18847553 Review.
-
Natural history and epidemiology of HPV infection and cervical cancer.Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S4-7. doi: 10.1016/j.ygyno.2008.07.045. Gynecol Oncol. 2008. PMID: 18760711 Review.
-
Epidemiology and natural history of genital human papillomavirus infection.J Am Osteopath Assoc. 2006 Mar;106(3 Suppl 1):S2-8. J Am Osteopath Assoc. 2006. PMID: 16729554 Review.
-
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.J Natl Cancer Inst. 2005 Apr 20;97(8):577-86. doi: 10.1093/jnci/dji073. J Natl Cancer Inst. 2005. PMID: 15840880
Cited by
-
Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches.BMC Infect Dis. 2020 Jul 8;20(1):482. doi: 10.1186/s12879-020-05083-7. BMC Infect Dis. 2020. PMID: 32640998 Free PMC article.
-
Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.Am J Public Health. 2013 Aug;103(8):1428-35. doi: 10.2105/AJPH.2012.301182. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763409 Free PMC article.
-
Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.Biomed Res Int. 2013;2013:892106. doi: 10.1155/2013/892106. Epub 2013 May 23. Biomed Res Int. 2013. PMID: 23781508 Free PMC article.
-
Prevalence of Human Papillomavirus (HPV) Genotypes among Women During 2015-2020 in Mashhad, Iran.Arch Iran Med. 2023 Aug 1;26(8):419-426. doi: 10.34172/aim.2023.64. Arch Iran Med. 2023. PMID: 38301103 Free PMC article.
-
[Prophylactic and therapeutic vaccines against human papilloma virus].HNO. 2010 Aug;58(8):778-90. doi: 10.1007/s00106-010-2118-6. HNO. 2010. PMID: 20544168 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical